Published in Journal of Clinical Oncology: Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
A multidisciplinary group of international experts in DNA Damage Response (DDR) and PARP inhibition, authored a review paper titled Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Access the journal at ascopubs.org
Download the slides covering selected highlights for your own use:
Additional resources on DDR and PARP inhibition
AstraZeneca has provided a sponsorship grant towards this independent programme